Evidence map›Paper›PMID 42738363›Full record

ArticleCancers2026

Benefit-Hematotoxicity Stratification in Patients with Triple-Negative Breast Cancer Receiving Platinum-Based Neoadjuvant Therapy: A Multitask Deep Learning Study.

Hao Sun, Xinglu Zhou, Jian Liang, Yujie Shi, Bao Deng, Ziqi Guo, Tong Su, Binbin Guo, Lei Zhong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hao SunDepartment of Breast Surgery, The Sixth Affiliated Hospital of Harbin Medical University, No. 998 Aiying Street, Songbei District, Harbin 150023, China.ORCID 0000-0003-2001-7056
Xinglu ZhouDepartment of PET/CT Center, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin 150081, China.
Jian LiangDepartment of Breast Surgery, The Sixth Affiliated Hospital of Harbin Medical University, No. 998 Aiying Street, Songbei District, Harbin 150023, China.
Yujie ShiDepartment of Breast Surgery, The Sixth Affiliated Hospital of Harbin Medical University, No. 998 Aiying Street, Songbei District, Harbin 150023, China.
Bao DengDepartment of Breast Surgery, The Sixth Affiliated Hospital of Harbin Medical University, No. 998 Aiying Street, Songbei District, Harbin 150023, China.
Ziqi GuoThe Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Nangang District, Harbin 150001, China.
Tong SuDepartment of Ultrasound, The Sixth Affiliated Hospital of Harbin Medical University, No. 998 Aiying Street, Songbei District, Harbin 150023, China.
Binbin GuoDepartment of Ultrasound, The Sixth Affiliated Hospital of Harbin Medical University, No. 998 Aiying Street, Songbei District, Harbin 150023, China.
Lei ZhongDepartment of Breast Surgery, The Sixth Affiliated Hospital of Harbin Medical University, No. 998 Aiying Street, Songbei District, Harbin 150023, China.

Funding

Harbin Medical University YJSCX202574HYDNational Natural Science Foundation of China 52272273Natural Science Foundation of Heilongjiang Province of China PL2024H153
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

multitask learningpathological complete responseplatinum-based neoadjuvant therapysevere hematotoxicitytriple-negative breast cancer

Identifiers

PMID42738363
PMCPMC13565154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.